Metabolic enzyme PFKFB4 promotes transcriptional co-activator SRC3 (nuclear receptor coactivator 3) for breast cancer carcinogenesis and is associated with poor prognosis of breast cancer [21]. This evidence concerns the gene NCOA3 and breast carcinoma.